| Quarterly Financials | Jun 2024 | Sept 2024 | Jun 2025 | Sept 2025 |
| Revenue | 317 | 299 | 353 | 413 |
| Expenses | 257 | 234 | 273 | 318 |
| EBITDA | 61 | 64 | 80 | 95 |
| Operating Profit % | 19 % | 21 % | 22 % | 23 % |
| Depreciation | 9 | 8 | 10 | 12 |
| Interest | 10 | 7 | 11 | 11 |
| Profit Before Tax | 41 | 49 | 60 | 72 |
| Tax | 16 | 15 | 16 | 18 |
| Net Profit | 26 | 35 | 43 | 54 |
| EPS in ₹ | 1.66 | 2.27 | 2.81 | 3.49 |










Kotak Midcap Fund Direct-Growth
Motilal Oswal Small Cap Fund Direct - Growth
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
HDFC Innovation Fund Direct-Growth
Mirae Asset Healthcare Fund Direct - Growth
Canara Robeco Manufacturing Fund Direct - Growth
PGIM India Flexi Cap Fund Direct-Growth
Bajaj Finserv Balanced Advantage Fund Direct-Growth
Edelweiss Recently Listed IPO Fund Direct-Growth 
